✦ LIBER ✦

CN3 IMMUNOTHERAPY WITH AUTOLOGOUS TUMOR CELL-BCG VACCINE (ONCOVAX®) IN PATIENTS WITH STAGE II COLON CANCER: MEDICAL AND ECONOMIC BENEFITS

✍ Scribed by CA Uyl-de Groot; MG Hanna; MT Groot; P Verboom; HC Hoover; JB Vermorken

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunotherapy with autologous tumor cell

✍ C.A. Uyl-de Groot; J.B. Vermorken; M.G. Hanna Jr.; P. Verboom; M.T. Groot; G.J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Adjuvant active specific immunotherapy o

✍ Michael G. Hanna Jr.; Herbert C. Hoover Jr.; Jan B. Vermorken; Jules E. Harris; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 559 KB

1326 Immune-regulatory (FoxP3+)-T-cell t

✍ C. Remondo; P. Tagliaferri; M.S. Rotundo; P. Tassone; M.T. Del Vecchio; C. Migal 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB